Please login first

Webinar on Personalized Medicine | Optimizing Treatment of Parkinson’s Disease

22 Nov 2022, 15:00 (CET)

Parkinsons Disease, Deviceaided Treatments, Therapy Optimization, Objective Movement Analysis
Bookmark
Bookmark event Remove event from bookmarks
Add this event to bookmarks
Event Registration Contact Us

Welcome from the Chair

2nd Webinar on Personalized Medicine

Optimizing Treatment of Parkinson’s Disease

Dear Colleagues,

Effective treatments for symptomatic control of Parkinson’s disease (PD) have developed during the last two decades. These include combinations of oral drugs as well as transdermal delivery and devices for subcutaneous and intestinal infusions that have been developed in parallel with deep-brain stimulation (DBS) for PD and other movement disorders.

Current research is expanding on optimization of treatment outcome in terms of efficacy, safety, and quality of life, and the rapid development of wearables and home-based monitoring technologies is encouraging.

Between November 2020 and January 2022, 10 papers were published in the Special Issue “Optimizing Treatment of Parkinson’s Disease”. The scope was the latest approaches for meeting the need of continuous individualization of the therapies.

It is a pleasure to invite you all to a webinar covering three of the articles from the Special Issue.

Kind regards,

Prof. Dr. Dag Nyholm

Date: 22 November 2022

Time: 3:00 pm CET | 9:00 am EST | 10:00 pm CST Asia

Webinar ID: 815 3418 1180

Webinar Secretariat: jpm.webinar@mdpi.com

Chair

Department of Medical Sciences, Neurology, Uppsala University, Sweden

DETAILS
Bio
Dag Nyholm is professor of neurology and specialist physician. His research is mostly focused on movement disorders - especially optimization of treatments in Parkinson's disease, but also cervical dystonia, essential tremor, Huntington's disease and normal pressure hydrocephalus.

Invited Speakers

Neuro Department, Karolinska University Hospital, Stockholm, Sweden and Center for Neurology, Akademiskt Specialistcentrum, Stockholm, Sweden

DETAILS
Bio
Clinical neurologist specialized in Movement Disorders. I am involved in both outpatient and inpatient care, from diagnosis to palliative care. Selecting and treating Parkinsons patients with device-aided therapies is an important part our units work, as well as participating in clinical research.

Department of neurology,University Hospital of Bispebjerg, Copenhagen, Denmark

DETAILS
Bio
MD University of Copenhagen 1987. Head of Clinic for complex Parkinson’s disease. Has been active in the treatment of the different aspects of Movement Disorders during the last two decades. Has been involved in DBS and pump therapies for advanced PD for 23 years. Has given a great number of lectures internationally on movement disorders, especially Parkinson’s disease. Has been chairman at a number of international meetings on Parkinson’s disease. Is the head of several courses in neurology. Is participating in a Scandinavian reference group writing guidelines for treatment of Parkinson’s disease. Has been an assistant professor in neurology at the University of Copenhagen for a number of years. Has been PI at a number of clinical trials in MDS. Is currently cochair of the Scandmodis. Is member of the CSPC and cochair of the MDS congress 2022. Is chair of the Danish Movement Disorder Society.

Department of neurology, Uppsala University Hospital, Sweden.

DETAILS
Bio
MBChB. June 2001 from medical college of Baghdad University at Baghdad, Iraq. Specialist degree in internal medicine, July 2012 at Capio Sankt Görans Hospital in Stockholm, Sweden. Specialist degree in neurology, November 2017 at Capio Sankt Görans Hospital in Stockholm, Sweden.

Program

Speaker/Presentation

Time in CET

Chair Professor Dag Nyholm

Chair Introduction

3:00 - 3:10 pm

Dr. Mathias Sundgren

Does Information From the Parkinson Kinetigraph™ (Pkg) Influence the Neurologist´S Treatment Decisions? – An Observational Study in Routine Clinical Care of Patients With Parkinson’s Disease

3:10 - 3:30 pm

Dr. Tove Henrikse

Continuous Subcutaneous Apomorphine Infusion in Parkinson’s Disease: A Single-Center, Long-Term Follow-up Study of the Causes for Discontinuation

3:30 - 3:50 pm

Dr. Mezin Öthman

Initial Experience of the Levodopa- Entacapone- Carbidopa Intestinal Gel in Clinical Practice

3:50 - 4:10 pm

Q&A

4:10 - 4:25 pm

Closing of Webinar

Chair Professor Dag Nyholm

4:25 - 4:30 pm

Webinar Content

To view this content, you need to be registered and logged in to Sciforum platform.

Relevant SI

Optimizing Treatment of Parkinson’s Disease
Guest Editors: Dr. Dag Nyholm and Dr. Filip Bergquist
Deadline for manuscript submissions: closed (5 November 2021)

Sponsors and Partners

Organizers

Top